Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,132,933
+$7,643,344 QoQ
Shares Held
748,181
+81.4% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#38
of 294 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Mar 31, 2025CallValue
$8,370,728
CallShares
348,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. BHVN ranks #16 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in BHVN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,132,933 | 748,181 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,489,589 | 412,481 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,398,910 | 212,481 | Shares | Sole | 2026-02-18 | |
| 2025-03-31 | $8,370,728 | 348,200 | Call | Sole | 2025-05-15 | |
| 2024-09-30 | $16,270,232 | 325,600 | Put | Sole | 2024-11-14 | |
| 2024-03-31 | $12,234,153 | 223,700 | Call | Sole | 2024-05-17 | |
| 2023-09-30 | $2,760,649 | 106,138 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,382,000 | 225,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $10,223,814 | 427,417 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,495,773 | 402,326 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $617,432 | 45,200 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $11,624,500 | 837,500 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||